Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer

By Goto Ayumu   Yamada Yasuhide   Hosokawa Ayumu   Ura Takashi   Arai Tatsuhiro   Hamaguchi Tetsuya   Muro Kei   Shimada Yasuhiro   Shirao Kuniaki  

International Journal of Clinical Oncology, Vol. 9, Iss. 5, 2004-10 ,pp. : 364-368

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon- -2c in patients with advanced colorectal cancer: final results of a randomised phase III study

By Hausmaninger H.   Moser R.   Samonigg H.   Mlineritsch B.   Schmidt H.   Pecherstorfer M.   Fridrik M.   Kopf C.   Nitsche D.   Kaider A.   Ludwig H.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

Capecitabine (Xeloda&unknown;) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma

By Twelves C.   Boyer M.   Findlay M.   Cassidy J.   Weitzel C.   Barker C.   Osterwalder B.   Jamieson C.   Hieke K.   on behalf of the Xeloda  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 597-604

Elsevier

Access to resources Recommend Favorite

A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy

By Chua D.T.T.   Kwong D.L.W.   Sham J.S.T.   Au G.K.H.   Choy D.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 736-741

Elsevier

Access to resources Recommend Favorite

Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy

By Bar-Sela Gil   Haim Nissim  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 251-254

Humana Press, Inc

Access to resources Recommend Favorite